Overview
Sweden simulation solutions provider's Q1 order intake grew
Q1 EBITDA and net loss narrowed compared to last year
Company cites improved sales efficiency and market recovery as drivers of growth
Result Drivers
MARKET RECOVERY - Co cited market recovery from tariffs, general uncertainty, and exchange rate volatility as supporting growth
REGIONAL SALES GROWTH - Net sales in EMEA and APAC increased 46% and 22% respectively; Americas declined 4% due to project timing
Company press release: ID:nMFN9CXR8d
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 EPS
-SEK 0.59
Q1 Net Income
-SEK 16.50 mln
Q1 EBITDA
-SEK 9.20 mln
Analyst Coverage
The one available analyst rating on the shares is "hold"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Mentice AB is SEK42.89, about 231.2% above its May 6 closing price of SEK12.95
The stock recently traded at 71 times the next 12-month earnings vs. a P/E of 162 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
